Left ventricular function impairment in patients with normal-weight obesity: Contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory activation

Circulation: Cardiovascular Imaging

Volumn 5, Issue 3, 2012, Pages 349-356

  Kosmala, Wojciech ^a   Jedrzejuk, Diana ^a   Derzhko, Roksolana ^a   Przewlocka Kosmala, Monika ^a   Mysiak, Andrzej ^a   Bednarek Tupikowska, Grazyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Echocardiography; Left ventricular function; Normal weight obesity

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; INSULIN; PROCOLLAGEN TYPE I CARBOXY TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; ANAMNESIS; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE INDEX; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; TISSUE DOPPLER IMAGING;

ABDOMINAL FAT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FIBROSIS; HEART VENTRICLES; HUMANS; IDEAL BODY WEIGHT; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84863713121     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.969956     Document Type: Article

References (42)

1. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J. 2006;27:96-106. (Pubitemid 41785938)
2. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-1962 Through 2007-2008 (June 2010). http://www.cdc.gov/nchs/data/hestat/obesity-adult-07-08/obesity-adult-07-08.htm. Accessed July 2,2011.
3. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF. Secular trends in cardiovascular disease risk factors according to body mass index in USadults. JAMA. 2005;293:1868-1874. (Pubitemid 40548183)
4. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313. (Pubitemid 34815352)
5. Kosmala W, Wong C, Kuliczkowska J, Leano R, Przewlocka-Kosmala M, Marwick TH. Use of body weight and insulin resistance to select obese patients for echocardiographic assessment of subclinical left ventricular dysfunction. Am J Cardiol. 2008;101:1334-1340.
6. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028-2037. (Pubitemid 350074800)
7. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.
8. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
9. Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo- Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez-Jimenez F. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32:959-966. (Pubitemid 351986216)
10. Franzosi MG. Should we continue to use BMI as a cardiovascular risk factor? Lancet. 2006;368:624-625. (Pubitemid 44223676)
11. Romero-Corral A, Somers VK, Sierra-Johnson J, Jensen MD, Thomas RJ, Squires RW, Allison TG, Korinek J, Lopez-Jimenez F. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J. 2007;28:2087-2093. (Pubitemid 47517439)
12. Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity? Eur Heart J. 2007;28:2047-2048. (Pubitemid 47517455)
13. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, Jensen MD, Parati G, Lopez-Jimenez F. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010;31:737-746.
14. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr. 2007;85:40-45. (Pubitemid 46067613)
15. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis. 2006;16:513-523. (Pubitemid 44794584)
16. Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring). 2011;19:624-630.
17. Shea JL, King MT, Yi Y, Gulliver W, Sun G. Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. Nutr Metab Cardiovasc Dis. January 5
18. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring). 2006;14(Suppl 5):242S-249S.
19. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53:577-584.
20. von Eyben FE, Mouritsen E, Holm J, Montvilas P, Dimcevski G, Suciu G, Helleberg I, Kristensen L, von Eyben R. Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord. 2003;27:941-949. (Pubitemid 36918616)
21. Park YW, Heymsfield SB, Gallagher D. Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord. 2002;26:978-983. (Pubitemid 34756182)
22. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72:694-701. (Pubitemid 30667089)
23. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography. J Am Soc Echocardiogr. 2005;18:1440-1463.
24. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458. (Pubitemid 16119719)
25. Kuznetsova T, Herbots L, Richart T, D'hooge J, Thijs L, Fagard RH, Herregods MC, Staessen JA. Left ventricular strain and strain rate in a general population. Eur Heart J. 2008;29:2014-2023.
26. Kowalski M, Kukulski T, Jamal F, D'hooge J, Weidemann F, Rademakers F, Bijnens B, Hatle L, Sutherland GR. Can natural strain and strain rate quantify regional myocardial deformation? A study in healthy subjects. Ultrasound Med Biol. 2001;27:1087-1097. (Pubitemid 32807731)
27. Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Int J Obes (Lond). 2008;32:763-771. (Pubitemid 351670619)
28. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003;41:611-617 (Pubitemid 36223327)
29. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110:3081-3087. (Pubitemid 39492002)
30. Vasan RS. Cardiac function and obesity. Heart. 2003;89:1127-1129. (Pubitemid 37163991)
31. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191-2196. (Pubitemid 38625396)
32. Wiklund P, Toss F, Weinehall L, Hallmans G, Franks PW, Nordström A, Nordström P. Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab. 2008;93:4360-4366. (Pubitemid 352789532)
33. Aucouturier J, Meyer M, Thivel D, Taillardat M, Duché P. Effect of android to gynoid fat ratio on insulin resistance in obese youth. Arch Pediatr Adolesc Med. 2009;163:826-831.
34. McCarty MF. A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. Med Hypotheses. 2003;61:173-176. (Pubitemid 36976176)
35. Picano E, Pelosi G, Marzilli M, Lattanzi F, Benassi A, Landini L, L'Abbate A. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation. 1990;81:58-64. (Pubitemid 20031767)
36. Bosch M, Lopez-Bermejo A, Vendrell J, Musri M, Ricart W, Fernandez-Real JM. Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass. Diabetologia. 2005;48:1841-1843. (Pubitemid 41317839)
37. Herder C, Baumert J, Kolb H, Koenig W, Martin S, Thorand B. Circulating levels of interleukin-18 independent of body fat and fat-free mass: results from the MONICA/KORA study. Diabetes Care. 2006;29: 174-175. (Pubitemid 44033462)
38. Skurk T, Kolb H, Müller-Scholze S, Röhrig K, Hauner H, Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol. 2005;152:863-868. (Pubitemid 40903576)
39. Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab. 2009;94:4472-4482.
40. Tsioufis CP, Tsiachris DL, Selima MN, Dimitriadis KS, Thomopoulos CG, Tsiliggiris DC, Gennadi AS, Syrseloudis DC, Stefanadi ES, Toutouzas KP, Kallikazaros IE, Stefanadis CI. Impact ofwaist circumference on cardiac phenotype in hypertensives according to gender. Obesity (Silver Spring). 2009;17:177-182. (Pubitemid 50310533)
41. Henry RM, Kamp O, Kostense PJ, Spijkerman AM, Dekker JM, van Eijck R, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD; Hoorn study. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flowmediated dilation: the Hoorn study. Diabetes Care. 2004;27:522-529. (Pubitemid 38174082)
42. Chen-Tournoux A, Khan AM, Baggish AL, Castro VM, Semigran MJ, McCabe EL, Moukarbel G, Reingold J, Durrani S, Lewis GD, Newton-Cheh C, Scherrer-Crosbie M, Kaplan LM, Wang TJ. Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels. Am J Cardiol. 2010;106:1450-1455.